To investigate the potential mechanism of bone loss following DOCA-salt-induced osteoporosis and LR-AC1 treatment, immunohistochemical (IHC) staining was performed targeting CD31+ and Osterix (Sp7). This evidence concerns the gene PECAM1 and osteoporosis.